PRINCIPALI PUBBLICAZIONI


1: Leandri M, Campbell J, Molfetta L, Barbera C, Tabaton M. Relationship between 
balance and cognitive performance in older people. J Alzheimers Dis.
2015;45(3):705-7.


2: Monacelli F, Borghi R, Cammarata S, Nencioni A, Piccini A, Tabaton M, Odetti
P. Amnestic mild cognitive impairment and conversion to Alzheimer's disease:
insulin resistance and glycoxidation as early biomarker clusters. J Alzheimers
Dis. 2015;45(1):89-95. 


3: Guglielmotto M, Monteleone D, Piras A, Valsecchi V, Tropiano M, Ariano S,
Fornaro M, Vercelli A, Puyal J, Arancio O, Tabaton M, Tamagno E. Aβ1-42 monomers 
or oligomers have different effects on autophagy and apoptosis. Autophagy. 2014
Oct 1;10(10):1827-43.

 

4: Piras S, Furfaro AL, Piccini A, Passalacqua M, Borghi R, Carminati E, Parodi
A, Colombo L, Salmona M, Pronzato MA, Marinari UM, Tabaton M, Nitti M. Monomeric 
Aβ1-42 and RAGE: key players in neuronal differentiation. Neurobiol Aging. 2014
Jun;35(6):1301-8.

 

5: Ientile L, De Pasquale R, Monacelli F, Odetti P, Traverso N, Cammarata S,
Tabaton M, Dijk B. Survival rate in patients affected by dementia followed by
memory clinics (UVA) in Italy. J Alzheimers Dis. 2013;36(2):303-9. 


6: Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M,
Colicchio S, Cattaneo CI, D'Angelo E, Fornaro P. Adjunctive agomelatine therapy
in the treatment of acute bipolar II depression: a preliminary open label study. 
Neuropsychiatr Dis Treat. 2013;9:243-51. 


7: Tamagno E, Guglielmotto M, Monteleone D, Vercelli A, Tabaton M.
Transcriptional and post-transcriptional regulation of β-secretase. IUBMB Life.
2012 Dec;64(12):943-50. 


8: Guglielmotto M, Monteleone D, Boido M, Piras A, Giliberto L, Borghi R,
Vercelli A, Fornaro M, Tabaton M, Tamagno E. Aβ1-42-mediated down-regulation of
Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation.
Aging Cell. 2012 Oct;11(5):834-44. 


9: Piccini A, Borghi R, Guglielmotto M, Tamagno E, Cirmena G, Garuti A, Pollero
V, Cammarata S, Fornaro M, Messa M, Colombo L, Salmona M, Perry G, Tabaton M.
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. J
Neurochem. 2012 Sep;122(5):1023-31. 


10: Di Maria E, Giorgio E, Uliana V, Bonvicini C, Faravelli F, Cammarata S,
Novello MC, Galimberti D, Scarpini E, Zanetti O, Gennarelli M, Tabaton M.
Possible influence of a non-synonymous polymorphism located in the NGF precursor 
on susceptibility to late-onset Alzheimer's disease and mild cognitive
impairment. J Alzheimers Dis. 2012;29(3):699-705. 


11: Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, Lee 
HG, Smith MA, Perry G, Zhu X. The earliest stage of cognitive impairment in
transition from normal aging to Alzheimer disease is marked by prominent RNA
oxidation in vulnerable neurons. J Neuropathol Exp Neurol. 2012 Mar;71(3):233-41.

 


12: Musicco M, Padovani A, Sorbi S, Scarpini E, Caffarra P, Cappa S, Clerici F,
Tabaton M, Caltagirone C, Bonavita V, Bruni AC, Bruno G, Federico A, Ferrarese C,
Marra C, Nacmias B, Parnetti L, Pettenati C, Sorrentino G, Tagliavini F, Mariani 
C. Position paper of the Italian Society for the study of Dementias (SINDEM) on
the proposal of a new lexicon on Alzheimer disease. Neurol Sci. 2012
Feb;33(1):201-8. 


13: Tamagno E, Guglielmotto M, Monteleone D, Tabaton M. Amyloid-β production:
major link between oxidative stress and BACE1. Neurotox Res. 2012
Oct;22(3):208-19. 


14: Castellani RJ, Gupta Y, Sheng B, Siedlak SL, Harris PL, Coller JM, Perry G,
Lee HG, Tabaton M, Smith MA, Wang X, Zhu X. A novel origin for granulovacuolar
degeneration in aging and Alzheimer's disease: parallels to stress granules. Lab 
Invest. 2011 Dec;91(12):1777-86. 


15: Guglielmotto M, Monteleone D, Giliberto L, Fornaro M, Borghi R, Tamagno E,
Tabaton M. Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway.
J Alzheimers Dis. 2011;27(4):871-83. 


16: Stone JG, Siedlak SL, Tabaton M, Hirano A, Castellani RJ, Santocanale C,
Perry G, Smith MA, Zhu X, Lee HG. The cell cycle regulator phosphorylated
retinoblastoma protein is associated with tau pathology in several tauopathies. J
Neuropathol Exp Neurol. 2011 Jul;70(7):578-87. 


17: Massone S, Vassallo I, Castelnuovo M, Fiorino G, Gatta E, Robello M, Borghi
R, Tabaton M, Russo C, Dieci G, Cancedda R, Pagano A. RNA polymerase III drives
alternative splicing of the potassium channel-interacting protein contributing to
brain complexity and neurodegeneration. J Cell Biol. 2011 May 30;193(5):851-66.

 


18: Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R,
Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, Pagano A. 
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling 
in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis. 2011
Feb;41(2):308-17. 


19: Borghi R, Piccini A, Barini E, Cirmena G, Guglielmotto M, Tamagno E, Fornaro 
M, Perry G, Smith MA, Garuti A, Tabaton M. Upregulation of presenilin 1 in brains
of sporadic, late-onset Alzheimer's disease. J Alzheimers Dis. 2010;22(3):771-5. 

 

20: Guglielmotto M, Aragno M, Tamagno E, Vercellinatto I, Visentin S, Medana C,
Catalano MG, Smith MA, Perry G, Danni O, Boccuzzi G, Tabaton M. AGEs/RAGE complex
upregulates BACE1 via NF-κB pathway activation. Neurobiol Aging. 2012
Jan;33(1):196.e13-27. 


21: Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A,
Pollero V, Novello C, Caltagirone C, Smith MA, Bossù P, Perry G, Odetti P,
Tabaton M. Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of
amnestic patients with mild cognitive impairment. Arch Neurol. 2010
Jul;67(7):867-72. 


22: Moh CF, Siedlak SL, Tabaton M, Perry G, Castellani RJ, Smith MA.
Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease. J
Neurosci Methods. 2010 Jul 15;190(2):244-7. 


23: Guglielmotto M, Giliberto L, Tamagno E, Tabaton M. Oxidative stress mediates 
the pathogenic effect of different Alzheimer's disease risk factors. Front Aging 
Neurosci. 2010 Feb 9;2:3. 


24: Lahiri DK, Maloney B. Beyond the signaling effect role of amyloid-ß42 on the 
processing of APP, and its clinical implications. Exp Neurol. 2010
Sep;225(1):51-4. 


25: Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA. Oxidative 
stress in Alzheimer disease: a possibility for prevention. Neuropharmacology.
2010 Sep-Oct;59(4-5):290-4. 

 

26: Tabaton M, Odetti P, Cammarata S, Borghi R, Monacelli F, Caltagirone C, Bossù
P, Buscema M, Grossi E. Artificial neural networks identify the predictive values
of risk factors on the conversion of amnestic mild cognitive impairment. J
Alzheimers Dis. 2010;19(3):1035-40. 


27: Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, Galimberti 
D, Ghidoni R, Gonella D, Novello C, Pollero V, Perroni L, Odetti P, Scarpini E,
Binetti G, Tabaton M. The H1 haplotype of the tau gene (MAPT) is associated with 
mild cognitive impairment. J Alzheimers Dis. 2010;19(3):909-14. 


28: Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, Cohen ML, Wang X, Siedlak
SL, Dwyer BE, Hayashi T, Nakamura M, Nunomura A, Perry G. Increased iron and free
radical generation in preclinical Alzheimer disease and mild cognitive
impairment. J Alzheimers Dis. 2010;19(1):363-72. 

 

29: Tabaton M, Perry G, Zhu X, Lee HG, Casadesus G, Smith MA. Memantine:
"hypothesis testing" not "disease modifying" in Alzheimer's disease. Am J Pathol.
2010 Feb;176(2):540-1. 


30: Su B, Wang X, Lee HG, Tabaton M, Perry G, Smith MA, Zhu X. Chronic oxidative 
stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci 
Lett. 2010 Jan 14;468(3):267-71. 


31: Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G,
Smith MA. Dissociated amyloid-beta antibody levels as a serum biomarker for the
progression of Alzheimer's disease: a population-based study. Exp Gerontol. 2010 
Jan;45(1):47-52. 

 

32: Tabaton M, Zhu X, Perry G, Smith MA, Giliberto L. Signaling effect of
amyloid-beta(42) on the processing of AbetaPP. Exp Neurol. 2010 Jan;221(1):18-25.

 


33: Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C, Fornaro 
M, Vitali A, Bracco L, Caltagirone C, Bossù P, Odetti P, Tabaton M.
Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment. 
J Alzheimers Dis. 2009;18(2):267-71. 


34: D'Arrigo C, Tabaton M, Perico A. N-terminal truncated pyroglutamyl beta
amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the
full-length Abeta1-42. Biopolymers. 2009 Oct;91(10):861-73. 


35: Tabaton M. Coffee "breaks" Alzheimer's disease. J Alzheimers Dis.
2009;17(3):699-700; discussion 701-2. 


36: Giliberto L, Borghi R, Piccini A, Mangerini R, Sorbi S, Cirmena G, Garuti A, 
Ghetti B, Tagliavini F, Mughal MR, Mattson MP, Zhu X, Wang X, Guglielmotto M,
Tamagno E, Tabaton M. Mutant presenilin 1 increases the expression and activity
of BACE1. J Biol Chem. 2009 Apr 3;284(14):9027-38. 


37: Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, Danni
O, Parola M, Smith MA, Perry G, Tamagno E, Tabaton M. The up-regulation of BACE1 
mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. 
J Neurochem. 2009 Feb;108(4):1045-56. 


38: Leandri M, Cammisuli S, Cammarata S, Baratto L, Campbell J, Simonini M,
Tabaton M. Balance features in Alzheimer's disease and amnestic mild cognitive
impairment. J Alzheimers Dis. 2009;16(1):113-20. 


39: Giliberto L, Zhou D, Weldon R, Tamagno E, De Luca P, Tabaton M, D'Adamio L.
Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the 
stress threshold of neurons and has a "regulated" transcriptional role. Mol
Neurodegener. 2008 Sep 2;3:12. 


40: Tamagno E, Guglielmotto M, Giliberto L, Vitali A, Borghi R, Autelli R, Danni 
O, Tabaton M. JNK and ERK1/2 pathways have a dual opposite effect on the
expression of BACE1. Neurobiol Aging. 2009 Oct;30(10):1563-73.


41: Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca
G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M. Oxidative
stress activates a positive feedback between the gamma- and beta-secretase
cleavages of the beta-amyloid precursor protein. J Neurochem. 2008
Feb;104(3):683-95. Epub 2007 Nov 14.

 

42: Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K,
Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL,
Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL,
Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. Classification
and prediction of clinical Alzheimer's diagnosis based on plasma signaling
proteins. Nat Med. 2007 Nov;13(11):1359-62. Epub 2007 Oct 14. 


43: Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura
A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation
of mitochondria in Alzheimer disease. Autophagy. 2007 Nov-Dec;3(6):614-5. Epub
2007 Aug 14. 


44: Tabaton M, Tamagno E. The molecular link between beta- and gamma-secretase
activity on the amyloid beta precursor protein. Cell Mol Life Sci. 2007
Sep;64(17):2211-8. Review. 


45: Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura
A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Autophagocytosis of mitochondria
is prominent in Alzheimer disease. J Neuropathol Exp Neurol. 2007
Jun;66(6):525-32. Erratum in: J Neuropathol Exp Neurol. 2007 Jul;

 

46: Piccini A, Zanusso G, Borghi R, Noviello C, Monaco S, Russo R, Damonte G,
Armirotti A, Gelati M, Giordano R, Zambenedetti P, Russo C, Ghetti B, Tabaton M. 
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease
molecular phenotype. Arch Neurol. 2007 May;


47: Tabaton M, Gambetti P. Soluble amyloid-beta in the brain: the scarlet
pimpernel. J Alzheimers Dis. 2006;9(3 Suppl):127-32. Review. 


48: Tamagno E, Bardini P, Guglielmotto M, Danni O, Tabaton M. The various
aggregation states of beta-amyloid 1-42 mediate different effects on oxidative
stress, neurodegeneration, and BACE-1 expression. Free Radic Biol Med. 2006 Jul
15;41(2):202-12. Epub 2006 Feb 14.


49: Pantieri R, Pardini M, Cecconi M, Dagna-Bricarelli F, Vitali A, Piccini A,
Russo R, Borghi R, Tabaton M. A novel presenilin 1 L166H mutation in a
pseudo-sporadic case of early-onset Alzheimer's disease. Neurol Sci. 2005
Dec;26(5):349-50. 


50: Odetti P, Piccini A, Giliberto L, Borghi R, Natale A, Monacelli F, Marchese
M, Assini A, Colucci M, Cammarata S, Tabaton M. Plasma levels of insulin and
amyloid beta 42 are correlated in patients with amnestic Mild Cognitive
Impairment. J Alzheimers Dis. 2005 Dec;8(3):243-5. 


51: Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A. Neprylisin decreases
uniformly in Alzheimer's disease and in normal aging. FEBS Lett. 2005 Nov
7;579(27):6027-30. Epub 2005 Oct 5. 


52: Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, Borghi R, Giliberto L,
Armirotti A, D'Arrigo C, Bachi A, Cattaneo A, Canale C, Torrassa S, Saido TC,
Markesbery W, Gambetti P, Tabaton M. beta-amyloid is different in normal aging
and in Alzheimer disease. J Biol Chem. 2005 Oct 7;280(40):34186-92. Epub 2005 Aug

 


53: Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis 
of Alzheimer's disease. Int J Exp Pathol. 2005 Jun;86(3):139-45. 

 


54: Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro 
G, Davit A, Danni O, Smith MA, Perry G, Tabaton M. Beta-site APP cleaving enzyme 
up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein
kinases pathways. J Neurochem. 2005 Feb;

 

55: Colucci M, Roccatagliata L, Capello E, Narciso E, Latronico N, Tabaton M,
Mancardi GL. The 14-3-3 protein in multiple sclerosis: a marker of disease
severity. Mult Scler. 2004 Oct;


56: Ricciarelli R, d'Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M.
Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life. 2004


57: Assini A, Cammarata S, Vitali A, Colucci M, Giliberto L, Borghi R, Inglese
ML, Volpe S, Ratto S, Dagna-Bricarelli F, Baldo C, Argusti A, Odetti P, Piccini
A, Tabaton M. Plasma levels of amyloid beta-protein 42 are increased in women
with mild cognitive impairment. Neurology. 2004 Sep 14;


58: Borghi R, Piccini A, Delacourte A, Strocchi P, Zaccheo D, Tabaton M. Protein 
levels of glycogen synthase 3 kinase are normal in progressive supranuclear
palsy. Neurosci Lett. 2004 Aug 5;


59: Zhu X, Wang Y, Ogawa O, Lee HG, Raina AK, Siedlak SL, Harris PL, Fujioka H,
Shimohama S, Tabaton M, Atwood CS, Petersen RB, Perry G, Smith MA.
Neuroprotective properties of Bcl-w in Alzheimer disease. J Neurochem. 2004
Jun;


60: Dozza B, Smith MA, Perry G, Tabaton M, Strocchi P. Regulation of glycogen
synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma
cells. J Neurochem. 2004 Jun;


61: Ricciarelli R, D'Abramo C, Zingg JM, Giliberto L, Markesbery W, Azzi A,
Marinari UM, Pronzato MA, Tabaton M. CD36 overexpression in human brain
correlates with beta-amyloid deposition but not with Alzheimer's disease. Free
Radic Biol Med. 2004 Apr 15;


62: Piccini A, Fassio A, Pasqualetto E, Vitali A, Borghi R, Palmieri D, Nacmias
B, Sorbi S, Sitia R, Tabaton M. Fibroblasts from FAD-linked presenilin 1
mutations display a normal unfolded protein response but overproduce Abeta42 in
response to tunicamycin. Neurobiol Dis. 2004 Mar;


63: Vitali A, Piccini A, Borghi R, Fornaro P, Siedlak SL, Smith MA, Gambetti P,
Ghetti B, Tabaton M. Soluble amyloid beta-protein is increased in frontotemporal 
dementia with tau gene mutations. J Alzheimers Dis. 2004 Feb;


64: Tabaton M, Monaco S, Cordone MP, Colucci M, Giaccone G, Tagliavini F, Zanusso
G. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease.
Ann Neurol. 2004 Feb;


65: Zhu X, Raina AK, Lee HG, Chao M, Nunomura A, Tabaton M, Petersen RB, Perry G,
Smith MA. Oxidative stress and neuronal adaptation in Alzheimer disease: the role
of SAPK pathways. Antioxid Redox Signal. 2003 Oct;


66: Tamagno E, Guglielmotto M, Bardini P, Santoro G, Davit A, Di Simone D, Danni 
O, Tabaton M. Dehydroepiandrosterone reduces expression and activity of BACE in
NT2 neurons exposed to oxidative stress. Neurobiol Dis. 2003 Nov;


67: Perry G, Castellani RJ, Smith MA, Harris PL, Kubat Z, Ghanbari K, Jones PK,
Cordone G, Tabaton M, Wolozin B, Ghanbari H. Oxidative damage in the olfactory
system in Alzheimer's disease. Acta Neuropathol. 2003 Dec;


68: Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton
M, Danni O. Multiple signaling events in amyloid beta-induced, oxidative
stress-dependent neuronal apoptosis. Free Radic Biol Med. 2003 Jul 

 

69: Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters
HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avíla J, Jones PK, Castellani RJ,
Smith MA, Perry G. Microtubule reduction in Alzheimer's disease and aging is
independent of tau filament formation. Am J Pathol. 2003 May;


70: Cupello A, Rapallino MV, Tabaton M, Lunardi GL. A simple, inexpensive, and
precise spectrophotometric method for evaluating the concentration of ascorbic
acid in CSF samples: data from different neurological pathologies. Int J
Neurosci. 2002 Nov;


71: Assini A, Terreni L, Borghi R, Giliberto L, Piccini A, Loqui D, Fogliarino S,
Forloni G, Tabaton M. Pure spastic paraparesis associated with a novel presenilin
1 R278K mutation. Neurology. 2003 Jan 14

 

72: Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K,
Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi 
K, Litvan I; Office of Rare Diseases of the National Institutes of Health. Office
of Rare Diseases neuropathologic criteria for corticobasal degeneration. J
Neuropathol Exp Neurol. 2002 Nov;


73: Forloni G, Terreni L, Bertani I, Fogliarino S, Invernizzi R, Assini A,
Ribizzi G, Negro A, Calabrese E, Volonté MA, Mariani C, Franceschi M, Tabaton M, 
Bertoli A. Protein misfolding in Alzheimer's and Parkinson's disease: genetics
and molecular mechanisms. Neurobiol Aging. 2002 Sep-Oct;


74: Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA,
Danni O, Smith MA, Perry G, Tabaton M. Oxidative stress increases expression and 
activity of BACE in NT2 neurons. Neurobiol Dis. 2002 Aug;


75: Passer B, Pellegrini L, Russo C, Siegel RM, Lenardo MJ, Schettini G, Bachmann
M, Tabaton M, D'Adamio L. Generation of an apoptotic intracellular peptide by
gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J
Alzheimers Dis. 2000 Nov;

 

76: Gambetti P, Parchi P, Capellari S, Russo C, Tabaton M, Teller JK, Chen SG.
Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other
conformational diseases. J Alzheimers Dis. 2001 Feb;


77: Borghi R, Pellegrini L, Lacaná E, Diaspro A, Pronzato MA, Vitali A, Roncarati
R, Strocchi P, Zaccheo D, D'Adamio L, Tabaton M. Neuronal apoptosis is
accompanied by amyloid beta-protein accumulation in the endoplasmic reticulum. J 
Alzheimers Dis. 2002 Feb;


78: Borghi R, Giliberto L, Assini A, Delacourte A, Perry G, Smith MA, Strocchi P,
Zaccheo D, Tabaton M. Increase of cdk5 is related to neurofibrillary pathology in
progressive supranuclear palsy. Neurology. 2002 Feb 26.

 


79: Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB,
Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL,
Jones PK, Petersen RB, Perry G, Smith MA. Mitochondrial abnormalities in
Alzheimer's disease. J Neurosci. 2001 May 1;


80: Zanusso G, Vattemi G, Ferrari S, Tabaton M, Pecini E, Cavallaro T, Tomelleri 
G, Filosto M, Tonin P, Nardelli E, Rizzuto N, Monaco S. Increased expression of
the normal cellular isoform of prion protein in inclusion-body myositis,
inflammatory myopathies and denervation atrophy. Brain Pathol. 2001
Apr.


81: Cavani S, Tamaoka A, Moretti A, Marinelli L, Angelini G, Di Stefano S, Piombo
G, Cazzulo V, Matsuno S, Shoji S, Furiya Y, Zaccheo D, Dagna-Bricarelli F,
Tabaton M, Mori H. Plasma levels of amyloid beta 40 and 42 are independent from
ApoE genotype and mental retardation in Down syndrome. Am J Med Genet. 2000 Nov.


82: Murialdo A, Marchese R, Abbruzzese G, Tabaton M, Michelozzi G, Schiavoni S.
Neurosyphilis presenting as progressive supranuclear palsy. Mov Disord. 2000
Jul;


83: Odetti P, Garibaldi S, Norese R, Angelini G, Marinelli L, Valentini S, Menini
S, Traverso N, Zaccheo D, Siedlak S, Perry G, Smith MA, Tabaton M.
Lipoperoxidation is selectively involved in progressive supranuclear palsy. J
Neuropathol Exp Neurol. 2000 May;


84: Russo C, Schettini G, Saido TC, Hulette C, Lippa C, Lannfelt L, Ghetti B,
Gambetti P, Tabaton M, Teller JK. Presenilin-1 mutations in Alzheimer's disease. 
Nature. 2000 Jun 1;


85: Borghi R, Marchese R, Negro A, Marinelli L, Forloni G, Zaccheo D, Abbruzzese 
G, Tabaton M. Full length alpha-synuclein is present in cerebrospinal fluid from 
Parkinson's disease and normal subjects. Neurosci Lett. 2000 Jun 16;287(1):


86: Piccini A, Ciotti MT, Vitolo OV, Calissano P, Tabaton M, Galli C. Endogenous 
APP derivatives oppositely modulate apoptosis through an autocrine loop.
Neuroreport. 2000 May 15;


87: Di Maria E, Tabaton M, Vigo T, Abbruzzese G, Bellone E, Donati C, Frasson E, 
Marchese R, Montagna P, Munoz DG, Pramstaller PP, Zanusso G, Ajmar F, Mandich P. 
Corticobasal degeneration shares a common genetic background with progressive
supranuclear palsy. Ann Neurol. 2000 Mar;

 

88: Paola D, Domenicotti C, Nitti M, Vitali A, Borghi R, Cottalasso D, Zaccheo D,
Odetti P, Strocchi P, Marinari UM, Tabaton M, Pronzato MA. Oxidative stress
induces increase in intracellular amyloid beta-protein production and selective
activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun.
2000 Feb 16;268(2):642-6. Erratum in: Biochem Biophys Res Commun 2000 May.


89: Marinelli L, Cammarata S, Nobbio L, Schenone A, Zaccheo D, Angelini G,
Tabaton M. Tyrosine kinase A-nerve growth factor receptor is antigenically
present in dystrophic neurites from a variety of conditions but not in
Alzheimer's disease. Neurosci Lett. 1999 Sep 24;

 

90: Pellegrini L, Passer BJ, Tabaton M, Ganjei JK, D'Adamio L. Alternative,
non-secretase processing of Alzheimer's beta-amyloid precursor protein during
apoptosis by caspase-6 and -8. J Biol Chem. 1999 Jul.


91: Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, Morbin M, 
Primavera A, Carella F, Solaro C, Grisoli M, Savoiardo M, Spillantini MG,
Tagliavini F, Goedert M, Ghetti B. Frontotemporal dementia and corticobasal
degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol. 1999 Jun;

 

92: Goedert M, Spillantini MG, Crowther RA, Chen SG, Parchi P, Tabaton M, Lanska 
DJ, Markesbery WR, Wilhelmsen KC, Dickson DW, Petersen RB, Gambetti P. Tau gene
mutation in familial progressive subcortical gliosis. Nat Med. 1999
Apr.


93: Russo C, Angelini G, Dapino D, Piccini A, Piombo G, Schettini G, Chen S,
Teller JK, Zaccheo D, Gambetti P, Tabaton M. Opposite roles of apolipoprotein E
in normal brains and in Alzheimer's disease. Proc Natl Acad Sci U S A. 1998 Dec.


94: Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M,
Perry G. Amyloid-beta deposition in Alzheimer transgenic mice is associated with 
oxidative stress. J Neurochem. 1998 May;70(5):2212-5. PubMed PMID: 9572310.


95: Odetti P, Angelini G, Dapino D, Zaccheo D, Garibaldi S, Dagna-Bricarelli F,
Piombo G, Perry G, Smith M, Traverso N, Tabaton M. Early glycoxidation damage in 
brains from Down's syndrome. Biochem Biophys Res Commun. 1998 Feb
24.


96: Galli C, Piccini A, Ciotti MT, Castellani L, Calissano P, Zaccheo D, Tabaton 
M. Increased amyloidogenic secretion in cerebellar granule cells undergoing
apoptosis. Proc Natl Acad Sci U S A. 1998 Feb 3.


97: Russo C, Saido TC, DeBusk LM, Tabaton M, Gambetti P, Teller JK. Heterogeneity
of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome 
brains. FEBS Lett. 1997 Jun 16;


98: Tabaton M, Perry G, Smith M, Vitek M, Angelini G, Dapino D, Garibaldi S,
Zaccheo D, Odetti P. Is amyloid beta-protein glycated in Alzheimer's disease?
Neuroreport. 1997 Mar 3;


99: Smith MA, Tabaton M, Perry G. Early contribution of oxidative glycation in
Alzheimer disease. Neurosci Lett. 1996 Oct 18;


100: Litvan I, DeLeo JM, Hauw JJ, Daniel SE, Jellinger K, McKee A, Dickson D,
Horoupian DS, Lantos PL, Tabaton M. What can artificial neural networks teach us 
about neurodegenerative disorders with extrapyramidal features? Brain. 1996
Jun;1

 

101: Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F,
Scartezzini P, Bertolini S, Mann DM, Tabaton M, Gambetti P. Presence of soluble
amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat
Med. 1996 Jan;


102: Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A,
Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. Validity and
reliability of the preliminary NINDS neuropathologic criteria for progressive
supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996
Jan;


103: Tabaton M, Rolleri M, Masturzo P, Cammarata S, Angelini G, Hansen LA, Saitoh
T, Petersen RB, Perry G, Richey P, et al. Apolipoprotein E epsilon 4 allele
frequency is not increased in progressive supranuclear palsy. Neurology. 1995
Sep;


104: Petersen RB, Tabaton M, Chen SG, Monari L, Richardson SL, Lynch T, Manetto
V, Lanska DJ, Markesbery WR, Lynches T [corrected to Lynch T], et al. Familial
progressive subcortical gliosis: presence of prions and linkage to chromosome 17.
Neurology. 1995 Jun;45(6):1062-7. Erratum in: Neurology 1995 Jul;


105: Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee
A, Tabaton M, Litvan I. Preliminary NINDS neuropathologic criteria for
Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology.
1994 Nov;


106: Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Soluble
amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in
cerebrospinal fluid. Biochem Biophys Res Commun. 1994 May 16;


107: Tabaton M. Research advances in the biology of Alzheimer's disease. Clin
Geriatr Med. 1994 May;


108: Petersen RB, Goldfarb LG, Tabaton M, Brown P, Monari L, Cortelli P, Montagna
P, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, et al. A novel mechanism of
phenotypic heterogeneity demonstrated by the effect of a polymorphism on a
pathogenic mutation in the PRNP (prion protein gene). Mol Neurobiol. 1994
Apr-Jun;


109: Gambetti P, Petersen R, Monari L, Tabaton M, Autilio-Gambetti L, Cortelli P,
Montagna P, Lugaresi E. Fatal familial insomnia and the widening spectrum of
prion diseases. Br Med Bull. 1993 Oct;


110: Cammarata S, Caponnetto C, Tabaton M. Ubiquitin-reactive neurites in
cerebral cortex of subjects with Huntington's chorea: a pathological correlate of
dementia? Neurosci Lett. 1993 Jun 25;


111: Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P,
Cortelli P, Julien J, Vital C, Pendelbury WW, et al. Fatal familial insomnia and 
familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA
polymorphism. Science. 1992 Oct 30;

 

112: Tabaton M, Cammarata S, Mandybur T, Richey P, Kawai M, Perry G, Gambetti P. 
Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid
precursor protein without cytoskeletal abnormalities. Brain Res. 1992 Oct
16;593(2):299-303. Erratum in: Brain Res 1993 Jan 8;

 

113: Petersen RB, Tabaton M, Berg L, Schrank B, Torack RM, Leal S, Julien J,
Vital C, Deleplanque B, Pendlebury WW, et al. Analysis of the prion protein gene 
in thalamic dementia. Neurology. 1992 Oct;4

 

114: Mancardi GL, Di Rocco M, Schenone A, Veneselli E, Doria M, Abbruzzese M,
Tabaton M, Borrone C. Hereditary motor and sensory neuropathy with deafness,
mental retardation and absence of large myelinated fibers. J Neurol Sci. 1992
Jul;

 

115: Cammarata S, Tabaton M. Ubiquitin-reactive axons have a widespread
distribution and are unrelated to prion protein plaques in Creutzfeldt-Jakob
disease. J Neurol Sci. 1992 Jul;1


116: Kawai M, Cras P, Richey P, Tabaton M, Lowery DE, Gonzalez-DeWhitt PA,
Greenberg BD, Gambetti P, Perry G. Subcellular localization of amyloid precursor 
protein in senile plaques of Alzheimer's disease. Am J Pathol. 1992
Apr;


117: Perry G, Cras P, Siedlak SL, Tabaton M, Kawai M. Beta protein
immunoreactivity is found in the majority of neurofibrillary tangles of
Alzheimer's disease. Am J Pathol. 1992 Feb;


118: Bianchini D, De Martini I, Cadoni A, Zicca A, Tabaton M, Schenone A, Anfosso
S, Akkad Wattar AS, Zaccheo D, Mancardi GL. GFAP expression of human Schwann
cells in tissue culture. Brain Res. 1992 Jan 20;


119: Tabaton M, Caponnetto C, Mancardi G, Loeb C. Amyloid beta protein deposition
in brains from elderly subjects with leukoaraiosis. J Neurol Sci. 1991
Dec.


120: Vande Weghe J, Cras P, Kawai M, Siedlak SL, Tabaton M, Greenberg B, Perry G.
Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer
disease. Brain Res. 1991 Sep 27;


121: Gheuens J, Cras P, Perry G, Boons J, Ceuterick-de Groote C, Lübke U, Mercken
M, Tabaton M, Gambetti PL, Vandermeeren M, et al. Demonstration of a novel
neurofilament associated antigen with the neurofibrillary pathology of Alzheimer 
and related diseases. Brain Res. 1991 Aug 30;


122: Perry G, Kawai M, Tabaton M, Onorato M, Mulvihill P, Richey P, Morandi A,
Connolly JA, Gambetti P. Neuropil threads of Alzheimer's disease show a marked
alteration of the normal cytoskeleton. J Neurosci. 1991 Jun;1


123: Mancardi GL, Cadoni A, Tabaton M, Schenone A, Zicca A, De Martini I,
Bianchini D, Damiani G, Zaccheo D. Schwann cell GFAP expression increases in
axonal neuropathies. J Neurol Sci. 1991 Apr;


124: Tabaton M, Cammarata S, Mancardi G, Manetto V, Autilio-Gambetti L, Perry G, 
Gambetti P. Ultrastructural localization of beta-amyloid, tau, and ubiquitin
epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci U S A. 1991
Mar 15.


125: Tabaton M, Cammarata S, Mancardi GL, Cordone G, Perry G, Loeb C. Abnormal
tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with
probable Alzheimer's disease. Neurology. 1991 Mar;41(3):391-4. 


126: Abbruzzese G, Tabaton M, Morena M, Dall'Agata D, Favale E. Motor and sensory
evoked potentials in progressive supranuclear palsy. Mov Disord. 1991;6(1):49-54.

 


127: Cammarata S, Mancardi G, Tabaton M. Formic acid treatment exposes hidden
neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients
with progressive supranuclear palsy and Alzheimer's disease. Neurosci Lett. 1990 
Jul 31;115(2-3):351-5.


128: Tabaton M, Mandybur TI, Perry G, Onorato M, Autilio-Gambetti L, Gambetti P. 
The widespread alteration of neurites in Alzheimer's disease may be unrelated to 
amyloid deposition. Ann Neurol. 1989 Dec;26(6):771-8. 

 

129: Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR.
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors
in prefrontal cortex and hippocampus. J Neurochem. 1989 Dec;53(6):1772-81. 


130: Tabaton M, Cammarata S, Manetto V, Perry G, Mancardi G. Tau-reactive
neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's
disease. Neurosci Lett. 1989 Sep 11;103(3):259-62. 


131: Manetto V, Abdul-Karim FW, Perry G, Tabaton M, Autilio-Gambetti L, Gambetti 
P. Selective presence of ubiquitin in intracellular inclusions. Am J Pathol. 1989
Mar;134(3):505-13. 


132: Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ,
Folstein MF, Price DL. Neuropathology of aminergic nuclei in Alzheimer's disease.
Prog Clin Biol Res. 1989;317:353-65. 


133: Autilio-Gambetti L, Morandi A, Kovacs DM, Tabaton M, Schaetzle B, Hauer C,
Groger RK, Tykocinski ML, Perry G, Greenberg BD, et al. Amyloid precursor protein
in cell cultures: a 130 kDa polypeptide. Prog Clin Biol Res. 1989;317:985-90.

 


134: Whitehouse PJ, Gambetti P, Harik SI, Kalaria RN, Perry G, Younkin SI,
Tabaton M, Unnerstall JR. Neurochemistry of dementia: establishing the links.
Prog Clin Biol Res. 1989;317:131-42. Review. 


135: Autilio-Gambetti L, Morandi A, Tabaton M, Schaetzle B, Kovacs D, Perry G,
Sharma S, Cornette J, Greenberg B, Gambetti P. The amyloid percursor protein of
Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell 
types. FEBS Lett. 1988 Dec 5;241(1-2):94-8. Erratum in: FEBS Lett 1989 Feb
27;244(2):509. 


136: Tabaton M, Whitehouse PJ, Perry G, Davies P, Autilio-Gambetti L, Gambetti P.
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive
supranuclear palsy. Ann Neurol. 1988 Sep;24(3):407-13.

 

137: Tabaton M, Perry G, Autilio-Gambetti L, Manetto V, Gambetti P. Influence of 
neuronal location on antigenic properties of neurofibrillary tangles. Ann Neurol.
1988 Jun;23(6):604-10. 


138: Manetto V, Perry G, Tabaton M, Mulvihill P, Fried VA, Smith HT, Gambetti P, 
Autilio-Gambetti L. Ubiquitin is associated with abnormal cytoplasmic filaments
characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A. 1988
Jun;85(12):4501-5. 


139: Mancardi GL, Cadoni A, Zicca A, Schenone A, Tabaton M, De Martini I, Zaccheo
D. HLA-DR Schwann cell reactivity in peripheral neuropathies of different
origins. Neurology. 1988 Jun;38(6):848-51.


140: Schenone A, De Martini I, Tabaton M, Romagnoli P, Akkad Wattar AS, Bianchini
D, Mancardi G. Direct immunofluorescence in sural nerve biopsies. Eur Neurol.
1988;28(5):262-9. 


141: Leonardi A, Arata L, Farinelli M, Cocito L, Schenone A, Tabaton M, Mancardi 
GL. Cerebrospinal fluid and neuropathological study in Devic's syndrome. Evidence
of intrathecal immune activation. J Neurol Sci. 1987 Dec;


142: Mancardi GL, Melioli G, Traverso F, Tabaton M, Farinelli M, Terragna A.
Zoster sine herpete causing encephalomyelitis. Ital J Neurol Sci. 1987
Feb;8(1):67-70.

 

143: Schenone A, Rolando S, Ferrari M, Romagnoli P, Tabaton M, Mancardi GL.
Peripheral neuropathy in Cockayne syndrome. Ital J Neurol Sci. 1986
Aug;7(4):447-52.


144: Tabaton M, Schenone A, Mancardi GL. Italian multicenter study of dementia: a
pathologically verified case of Alzheimer disease. Ital J Neurol Sci. 1986
Feb;7(1):161-3. 


145: Cammarata S, Schenone A, Pasquali GF, Tabaton M. Complete bilateral
relapsing ophthalmoplegia in a diabetic patient with a sensory-motor distal
polyneuropathy. Eur Neurol. 1986;25(4):278-80. 


146: Marmont AM, Mancardi GL, Tabaton M, Siccardi M, Grassia L, Schenone A,
Repetto M. Monoclonal IgM-associated demyelinating peripheral neuropathy: an
expression of monoclonal autoimmunity. Haematologica. 1985 Nov-Dec;70(6):471-6.

 


147: Tabaton M, Mancardi G, Loeb C. Generalized chorea due to bilateral small,
deep cerebral infarcts. Neurology. 1985 Apr;35(4):588-9. 


148: Tabaton M, Schenone A, Romagnoli P, Mancardi GL. A quantitative and
ultrastructural study of substantia nigra and nucleus centralis superior in
Alzheimer's disease. Acta Neuropathol. 1985;68(3):218-23. 

 

149: Mancardi GL, Tabaton M, Liwnicz BH. Endothelial mitochondrial content of
cerebral cortical capillaries in Alzheimer's disease. An ultrastructural
quantitative study. Eur Neurol. 1985;24(1):49-52. 


150: Mancardi GL, Schenone A, Tabaton M, Tassinari T, Mainardi P. Polyglucosan
bodies in the sural nerve of a diabetic patient with polyneuropathy. Acta
Neuropathol. 1985;66(1):83-6. 


151: Nahum M, Ferraris R, Tabaton M, Gandolfo C, Albano C, Fulcheri E. [Alcoholic
beri-beri: a not yet clearly understood pathogenesis. Problems presented by a
particularly clinical complex case]. Minerva Med. 1984 Oct 6;75(38):2193-8.
Italian. 


152: Primavera A, Tabaton M, Leonardi A. Periodic lateralized discharges in
Creutzfeldt-Jakob disease: serial electroencephalographic studies. Rev
Electroencephalogr Neurophysiol Clin. 1984 Apr;13(4):379-82. 


153: Bugiani O, Tabaton M, Cammarata S. Huntington's disease: survival of large
striatal neurons in the rigid variant. Ann Neurol. 1984 Feb;15(2):154-6. 


154: Loeb C, Mancardi GL, Tabaton M. Locked-in syndrome in acute inflammatory
polyradiculoneuropathy. Eur Neurol. 1984;23(2):137-40. 


155: Piccardo A, Tabaton M, Meneghini S, Leonardi A. [Corticocerebellar form of
Creutzfeldt-Jakob disease. Anatomo-clinical study]. Pathologica. 1983
Jul-Aug;75(1038):577-81. Italian. 


156: Bugiani O, Piola P, Tabaton M. Nontraumatic dissecting aneurysm of the
basilar artery. Eur Neurol. 1983;22(4):256-60. 


157: Leonardi A, Mancardi GL, Gherardi GF, Cocito L, De Martini I, Tabaton M.
Skin fibroblasts in Huntington's disease. An electron microscopic study. Eur
Neurol. 1983;22(4):283-8. 


158: Tabaton M, Bugiani O, Mancardi GL, Leonardi A, Demartini I, Primavera A.
Creutzfeldt-Jakob disease in the city and district of Genoa: estimated mortality 
rate in the six year period 1974-1979. Ital J Neurol Sci. 1981 May;2(2):189-92.

 

159: Mancardi GL, Bugiani O, Primavera A, Leonardi A, De Martini I, Tabaton M,
Cammarata S. Early myoclonus and quasiperiodic EEG changes in non-familial
Alzheimer's disease. Ital J Neurol Sci. 1980 Jun;1(3):183-7. 

CONTATTI

mtabaton@neurologia.unige.it

CEL: 3470646063

Studio Gazzerro 

Piazza Borgo Pila 3

16129 GENOVA (GE)

TEL.: 010588952

Studio medico

Via Cascione 51

18100 IMPERIA (IM)

TEL: 3479114686

Studio Medico

Via Ciarli 18

17019 VARAZZE (SV)

TEL: 3479114686

Stampa Stampa | Mappa del sito
© Massimo Tabaton